Redington AN. Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning.
TIMELY AND EFFICIENT REPERFUSION therapy remains the main therapeutic strategy for treating myocardial infarction. However, paradoxically, restoration of blood flow to the culprit coronary artery results in a predictable reperfusion injury that itself has become a therapeutic target (7, 20) . In 1986 Murry et al. (35) reported that repeated short episodes of ischemia instituted before index ischemia resulted in a significant decrease in experimental infarct size (IS) caused by local coronary ischemia-reperfusion (I/R) injury. They described this phenomenon as ischemic preconditioning (IPC). In experimental studies, IPC has consistently been shown to be one of the most effective therapies for protecting the myocardium against I/R injury. Its clinical applicability has been limited, however. The phenomenon that myocardial protection can be induced by preconditioning adjacent tissues (e.g., other coronary vascular beds) (39) or remote organs, for example, kidney (14) , or with a combination of reduced blood flow and electrical stimulation of the hindlimb (5) established the concept of "remote preconditioning." While seminal, these studies were also of limited clinical utility. It has recently been shown that short episodes of limb ischemia with a blood pressure cuff or tourniquet can also induce remote preconditioning, resulting in a reduction in IS by 50% in porcine myocardial infarction (27) and heart transplantation (30) models, thus providing a simple, noninvasive therapy that can easily be applied to clinical practice (9, 19, 23) . However, remote preconditioning has to be delivered before the onset of a predictable ischemic event, which constitutes a barrier for its clinical application in the setting of evolving myocardial infarction, for example. This limitation was potentially overcome by Zhao et al. (53) , who described cardioprotection by ischemic postconditioning (PostC). While subsequent protocols have varied, PostC in the study of Zhao et al. started during the initial moments of reperfusion, with three cycles of 30-s reperfusion followed by 30 s of reocclusion of the previously occluded coronary artery. It has recently been shown that PostC can be induced remotely and confers the same protective stimulus for the heart (26) .
Although local PostC and remote PostC provide a novel practical therapeutic approach, it has been suggested that the protection of PostC is less potent than classical IPC (see Ref. 46 for review). It has also been shown that there is a relatively narrow time window for delivering effective PostC, limited to the first few minutes of reperfusion (29) . Consequently, additional maneuvers to provide cardioprotection might enhance the effect. The finding that the protection offered by remote IPC was mediated by either humoral factors (5, 1) that persist in the blood or neurogenic pathway (14, 33, 43) suggested that this therapy could be commenced during the index ischemic period, in order to protect against reperfusion. Indeed, our previous data (42) confirmed that when the same protocol of remote "pre" conditioning was administered during the index ischemia period, a significant reduction in IS, similar to that achieved with standard remote IPC, was possible, a phenomenon we described as remote ischemic "per" conditioning (PerC). It has been shown that protection against I/R injury produced by either IPC or PostC involves activation of the reperfusion injury salvage kinase (RISK) pathway, among which phosphatidylinositol 3-kinase (PI3K)-Akt and the mitogen-activated protein kinase p44/p42 extracellular signal-regulated kinase (ERK)1/2 play important roles (18) . We hypoth-esized that PostC does not fully activate the RISK pathway. Therefore, we aimed to validate the concept that survival kinases can be further activated when PostC is combined with PerC, leading to better cardioprotection. We first aimed to assess whether PerC protects in a dose-dependent fashion when added to PostC. Second, we aimed to assess whether the combination of PostC and optimal PerC results in improved kinase signaling and, by using selective blockade, whether this activation is integral to the cardioprotection provided. Finally, we aimed to test whether the survival kinase activation and cardioprotection can be further enhanced when IPC is combined with PostCϩPerC.
MATERIALS AND METHODS

Animals
Eight-week-old male Sprague-Dawley (SD) rats, weighing between 250 and 280 g (Experimental Animal Center, Fudan University, Shanghai, China) were studied. The animal research study protocol was in compliance with the Guide for the Care of Use of Laboratory Animals published by the National Institutes of Health (NIH Pub. No. 85-23, revised 1996) and approved by the Animal Care Committee of Shanghai Sixth Hospital, Shanghai Jiao Tong University School of Medicine. All rats were housed for 2 wk as an acclimatization period before the experiments.
Surgical Preparation
After anesthesia with pentobarbital sodium (50 mg/kg ip) and endotracheal intubation, animals were ventilated (Animal Respirator DW-2000, Alcott Biotech, Shanghai, China) with room air at 45-60 breaths/min with the tidal volume set to 1.0 ml/100 g wt and body temperature maintained at 37°C with a heating pad and monitored with a thermometer. With a sterile surgical procedure, the right carotid artery was cannulated with a 24-gauge angiocatheter connected to a fluid-filled pressure transducer (sampling rate of 1 KHz; MPA-CFS, Alcott Biotech, Shanghai, China). The tube was passed retrogradely into the left ventricle (LV), and LV pressure tracings were digitized with an analog-to-digital converter and stored in a PC computer for later analysis. Left ventricular end-diastolic pressure (LVEDP) and the maximal rate of pressure rise/fall (ϮdP/dt max) were analyzed in a blinded fashion with dedicated software (MPC Systems, 2000M). Mean arterial pressure (MAP) was also monitored with a femoral artery cutdown approach similar to the method described above.
Left thoracotomy was performed through the fourth or fifth intercostal space, and the ribs were gently retracted to expose the heart. After pericardiotomy, the left coronary artery (LCA) was encircled by a 6-0 Prolene suture just distal to its first branch, and its ends were threaded through polyethylene tubing (PE-50) to form a snare for reversible coronary artery occlusion. Before LCA occlusion, the animals were anticoagulated (150 U/kg sodium heparin) and received an injection of lidocaine (4 mg/kg) that has been shown to prevent malignant arrhythmia without affecting the cardioprotective effects (26) . Cardiac ischemia was confirmed by a pale area below the suture or ST-T elevation shown in ECG that gradually became cyanotic, while reperfusion was characterized by rapid disappearance of cyanosis followed by vascular blush.
I/R Model with Different Ischemic Conditioning Interventions
The I/R model was created with 45-min coronary ligation followed by 2-h reperfusion with an open-chest surgical approach as described above. IPC was delivered with four cycles of 5-min coronary ligation followed by 5-min reperfusion before index ischemia started. PostC intervention was commenced at the beginning of reperfusion with six cycles of 10 s of reperfusion followed by 10-s reocclusion (29) . PerC stimulus was described in detail in our previous study (42) . Briefly, PerC was delivered during the index ischemia period and was created with the occlusion of blood flow to one hindlimb by tourniquet, which was validated by disappearance of Doppler blood flow of the femoral artery (SonoSite, M-Turbo System, L38X 5-10 MHz). The PerC protocols of ischemia and reperfusion duration and cycle number were varied as shown in Fig. 1 , and each protocol of PerC was delivered at the end of index ischemia and completed just before reperfusion started.
Area at Risk and IS Determination
After death, the LCA was reoccluded and 2% Evans blue dye was retrogradely injected into the ascending aorta to delineate the area at risk. The heart was then cut into five or six transverse slices, followed by incubation for 15 min at 37°C in a phosphate-buffered 1% 2,3,5-triphenyltetrazolium chloride solution to determine infarcted myocardium. The extent of the area of necrosis was quantified by computerized planimetry and corrected for the weight of the tissue slices. IS was expressed as the percentage of total weight of the LV at-risk area.
Superoxide Anion Generation Measured by Lucigenin-Enhanced Chemiluminescence
The lucigenin-enhanced chemiluminescence assay was used to determine superoxide anion production (36) . Fresh heart tissue was immediately homogenized in a 20 mM sodium phosphate buffer (pH 7.4) containing 0.01 mM EDTA and centrifuged at 1,000 g and 4°C for 10 min. The supernatant was obtained immediately for quantification. Buffer containing lucigenin (5 M) was measured for 5 min as background chemiluminescence, an aliquot of 100 l of supernatant was then added, and the chemiluminescence was measured for 30 min at room temperature (Sirius Luminometer, Berthold, Germany). Superoxide anion levels were expressed as relative light units per second after subtraction of background activity.
Determination of Malondialdehyde Activity
Tissue malondialdehyde (MDA) was quantified for each time point as described in the protocol to estimate the time course of changes in lipid peroxidation induced by I/R injury. Briefly, myocardium obtained from the area at risk was homogenized in 1.0 ml of 20 mM Tris·HCl, pH 7.4, containing 5 mM butylated hydroxytoluene. Lipid peroxides were assayed with a commercially available kit (catalog no. 437639, Calbiochem), and activity of MDA was expressed as micromolar per gram of protein (29) .
Western Blotting
Western blotting was performed on myocardium from the area at risk obtained at 15 min of reperfusion for quantification of Akt and ERK1/2 phosphorylation and on heart tissue from the area at risk collected at the end of reperfusion for Bcl-2 and Bax expression ratio measurement. After homogenization and protein quantification, ϳ40 g of protein from each sample was separated in 12% Tris-glycine SDS gels by electrophoresis and then transferred to polyvinylidene difluoride (PVDF) membranes. After blocking with 5% BSA in Tris buffer, membranes were incubated with the primary antibodies for Bcl-2 (New England Biolab; dilution 1:200) and Bax (Santa Cruz Biotechnology; dilution 1:200) to quantify apoptotic signaling and primary antibodies against phospho-Akt (serine 473), phospho-ERK1/2 (threonine 202/tyrosine 204), total Akt, and total ERK (Cell Signaling Technology) to quantify salvage signaling pathways. Horseradish peroxidase (HRP)-conjugated secondary antibody was then used. An ECL Western blotting detection kit (Pierce) was finally used to measure immunoreaction with a light-sensitive film (Kodak). The band for each protein was then quantified by densitometry with Image J software (version 1.41, NIH) and normalized to the expression of ␤-actin (Santa Cruz Biotechnology) for protein loading.
Terminal Deoxynucleotidyltransferase-Mediated dUTP Nick End Labeling Staining
Terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) staining was performed with a commercially available kit (Roche, Germany), according to the manufacturer's instructions, on heart tissue slices randomly selected from each group. Tissue sections were examined microscopically at ϫ400 magnification, and at least 100 cells from the peri-infarct area were counted in 10 fields (Leica Q500MC). The peri-infarct area was predetermined by hematoxylin and eosin staining performed on the adjacent tissue slide. The apoptotic index (AI) was calculated as follows: AI (%) ϭ number of apoptotic cells/total number counted ϫ 100.
Experimental Protocols
The I/R injury model was induced with 45-min ischemia with LCA coronary ligation followed by 2-h reperfusion. Forty-five minutes was selected because it is generally accepted that in animal experiments PostC is most effective when index ischemia duration is between 30 and 60 min (34, 46, 49) .
Protocol I. In previous studies (29) it has been shown that in the rat I/R model maximal protection against myocardial I/R injury was achieved by using a PostC protocol of six cycles of 10-s reperfusion followed by 10-s coronary reocclusion. Thus we hypothesized that additive effects might be achieved when this PostC regime was combined with a PerC protocol of four cycles of 5-min limb ischemia followed by 5-min reperfusion given during a 45-min index ischemia period (the "time-limited" maximal protocol). However, we also explored whether other protocols involving fewer and shorter cycles of PerC might provide different degrees of additive protection. Thus SD rats were randomly assigned to the 1) ischemia ϩ reperfusion group (IR group; n ϭ 5) or the 2) PostC group (n ϭ 5), and PostC-treated groups received different protocols of PerC intervention including the 3) PostC ϩ PerC(1ϫ5=) group (n ϭ 5), in which PostC-treated groups received one cycle of PerC with 5-min limb ischemia followed by 5-min reperfusion, 4) PostC ϩ PerC(2ϫ5=) group (n ϭ 5), in which PostC-treated groups received two cycles of PerC with 5-min limb ischemia followed by 5-min reperfusion, 5) PostC ϩ PerC(3ϫ5=) group (n ϭ 5), in which PostC-treated groups received three cycles of PerC with 5-min limb ischemia followed by 5-min reperfusion, 6) PostC ϩ PerC(4ϫ5=) group (n ϭ 5), in which PostC-treated groups received four cycles of PerC with 5-min limb ischemia followed by 5-min reperfusion, 7) PostC ϩ PerC(4ϫ3=) group (n ϭ 5), in which PostC-treated groups received four cycles of PerC with 3-min limb ischemia followed by 3-min reperfusion, and 8) PostC ϩ PerC(4ϫ1=) group (n ϭ 5), in which PostC-treated groups received four cycles of PerC with 1-min limb ischemia followed by 1-min reperfusion ( Fig. 1) .
At the completion of 2-h reperfusion, all the rats from each group were killed for IS quantification. After a 10-min stabilization period they were randomly assigned into 8 groups: 1) ischemia ϩ reperfusion (IR) group, in which rats further received 45-min coronary ligation followed by 2-h reperfusion; 2) postconditioning (PostC) group, in which rats received PostC intervention delivered at the initial 2 min of reperfusion period with 6 cycles of 10-s coronary reperfusion followed by 10-s coronary reocclusion; 3) PostC ϩ perconditioning (PostCϩPerC)(1ϫ5=) group, in which rats received both PostC therapy and 1 cycle of PerC maneuver defined as 5-min limb ischemia followed by 5-min reperfusion (see text for details); 4) PostCϩPerC(2ϫ5=) group, in which rats were given both PostC and 2 cycles of PerC therapy as described above; 5) PostCϩPerC(3ϫ5=) group, in which IR group rats were given both PostC and 3 cycles of PerC therapy; 6) PostCϩPerC(4ϫ5=) group, in which IR group rats were given both PostC and 4 cycles of PerC therapy; 7) PostCϩPerC(4ϫ3=) group, in which rats received both PostC and 4 cycles of PerC therapy for which the limb ischemia and reperfusion duration time was shortened to 3 min; and 8) PostCϩPerC(4ϫ1=) group, in which rats received both PostC and 4 cycles of PerC therapy for which the limb ischemia and reperfusion duration time was shortened to 1 min. At the completion of 2-h reperfusion, all rats for each group were killed for infarct size (IS) measurement. TTC, 2,3,5-triphenyltetrazolium chloride.
Protocol IIA. Protocol IIA aimed to assess whether the combination of PostC with PerC (4 cycles of 5-min ischemia followed by 5-min reperfusion, PostCϩPerC) can result in superior protection compared with PostC, PerC, or IPC alone and to test whether this improved cardiac protection was due to increased survival kinase activation, specifically, the levels of Akt and ERK1/2 phosphorylation. SD rats were randomly assigned to the following groups: 1) IR group, 2) IPC group, 3) PostC group, 4) PerC group with four cycles of 5-min limb ischemia followed by 5-min reperfusion, and 5) PostCϩPerC group, in which PostC was combined with PerC of four cycles of 5-min limb ischemia followed by 5-min reperfusion. At the completion of 2-h reperfusion, eight rats from each group were killed for IS quantification to assess the protection against I/R injury. Fig. 2 . In protocol IIA (A), SD rats were randomly assigned into 5 groups: 1) IR group, in which SD rats underwent open-chest operation and after a 50-min stabilization period, ischemia-reperfusion (I/R) injury was induced with 45-min coronary ligation followed by 2-h reperfusion; 2) IPC group, in which after a 10-min stabilization period IR group rats received ischemic preconditioning (IPC) therapy, which was defined as 4 cycles of 5-min coronary ligation followed by 5-min reperfusion after which I/R injury was induced as described above; 3) PostC group, in which rats underwent the same procedure as IR group rats except that reperfusion was started with 6 cycles of 10-s coronary reperfusion followed by 10-s coronary reocclusion; 4) PerC group, in which IR group rats received PerC therapy delivered with 4 cycles of 5-min limb ischemia followed by 5-min reperfusion (see text for details); and 5) PostCϩPerC group, in which IR group rats were given both PostC and PerC treatments as described above. Some rats for each group were killed for IS measurement at the completion of 2-h reperfusion, while other rats were killed at 15 min of reperfusion for Western blotting to quantify activity of signaling pathways. In Protocol IIB (B), SD rats were randomly assigned into 6 groups: 1) IR group SD rats underwent open-chest operation, and after 10-min stabilization period IR injury was induced as described above [IR rats received intravenous (IV) vehicle (DMSO) 10 min before reperfusion started]; 2) IR group rats received LY-294002 (LY) as an IV bolus 10 min before reperfusion started; 3) IR group rats received PD-98059 (PD) as an IV bolus 10 min before reperfusion started; 4) PostCϩPerC group, in which PostCϩPerC-treated IR rats received vehicle (DMSO) 10 min before reperfusion started; 4) PostCϩPerCϩLY group, in which PostCϩPerC-treated rats received LY-294002 as an IV bolus 10 min before reperfusion started; and 5) PostCϩPerCϩPD group, in which PostCϩPerC-treated rats received IV PD-98059 as a bolus 10 min before reperfusion started. Some rats from each group were killed for IS measurement at the completion of 2-h reperfusion, while other rats were killed at 15 min of reperfusion for Western blotting to quantify the activity of signaling pathways.
A total of 36 rats from each group were euthanized at 1, 5, 10, 30, 60, and 120 min after reperfusion (6 rats for each time point). LV heart tissue from the area at risk was obtained and used to detect the dynamic changes in reactive oxygen species (ROS) generation. One cross section of LV myocardium (ϳ5 mm thick) at the papillary muscle level was obtained from rats that finished the 2-h reperfusion and fixed in 10% formalin and paraffin embedded for TUNEL staining. LV myocardium from the area at risk was also obtained at 2 h of reperfusion for quantification of Bcl-2 and Bax protein expression levels.
Another six rats from each group were killed at 15 min of reperfusion, and LV myocardium from the risk area was obtained and used for Akt and ERK1/2 phosphorylation quantification. All LV tissues obtained from each rat were snap frozen in liquid nitrogen and stored in a freezer at Ϫ80°C (Fig. 2A) .
Protocol IIB. Protocol IIB aimed to assess how the cardioprotection afforded by PostCϩPerC was modified by PI3K and ERK1/2 inhibitors.
Thirty-six SD rats were studied for IS quantification and randomly assigned to the following groups: 1) IR group (n ϭ 6), in which I/R rats only received vehicle [dimethyl sulfoxide (DMSO) Ͻ300 g/kg] delivered 10 min before reperfusion by intravenous injection through the right external jugular vein; 2) IRϩLY group (n ϭ 6), in which the PI3K-selective inhibitor LY-294002 (LY, 0.3 mg/kg; Calbiochem) dissolved in DMSO (DMSO Ͻ300 g/kg) was administered via the right external jugular vein 10 min before reperfusion; 3) IRϩPD group (n ϭ 6), in which the ERK1/2 inhibitor PD-98059 (PD, 0.3 mg/kg; Calbiochem) diluted in DMSO (DMSO Ͻ300g/kg) was given in the same way as LY 10 min before reperfusion; 4) PostCϩPerC group (n ϭ 6), in which PostCϩPerC-treated rats received vehicle (DMSO Ͻ300 g/kg) administered 10 min before reperfusion; 5) PostCϩPerC ϩLY group (n ϭ 6), in which PostCϩPerC-treated rats received LY in the same way as described above; and 6) PostCϩPerCϩPD group, in which PostCϩPerC-treated rats (n ϭ 6) received PD in the same way as described above (Fig. 2B) . The selective inhibitory effect of both PD and LY has been validated in a previous study (24) . At the completion of 2-h reperfusion, all rats from each group were killed for IS quantification.
Another 30 SD rats (5 rats from each group) underwent the same experiment as described above and were killed at 15 min of reperfusion; LV tissue from the area at risk was obtained and used for Western blotting to quantify the levels of Akt and ERK1/2 phosphorylation.
Protocol III. Protocol III was designed to assess whether the protective effects of a combination of PostC and PerC are additive to IPC therapy, and how Akt and ERK1/2 activity is altered when these three interventions are combined.
Twenty SD rats were studied for IS quantification and randomly assigned to the following groups: 1) IR group (n ϭ 5); 2) IPC group (n ϭ 5); 3) PostCϩPerC group (n ϭ 5); and 4) IPCϩPostCϩPerC group (n ϭ 5), in which IPC-treated rats also received PostCϩPerC intervention (Fig. 3) . At the completion of 2-h reperfusion, all rats from each group were killed for IS quantification.
Another 20 SD rats (5 rats from each group) underwent the same procedure as described above and were killed at 15 min of reperfusion; LV tissue from the risk area was obtained and used for Western blotting to quantify Akt and ERK1/2 phosphorylation levels.
Statistical analysis. All data are expressed as means Ϯ SD. Differences in the hemodynamic indexes were compared within the groups by using repeated-measures ANOVA and between groups by using two-way ANOVA followed by least significant difference (LSD) corrected multiple comparisons. ROS generation including lucigenin-enhanced chemiluminescence and MDA accumulation was analyzed by two-way ANOVA followed by LSD corrected multiple comparisons. One-way ANOVA test followed by LSD correction was used for comparing the difference in all other variables between groups. A P value of Ͻ0.05 was considered statistically significant. Statistical analyses were performed with SPSS 13.0 statistics software (SPSS, Chicago, IL).
RESULTS
Cardioprotection by PerC is Additive to PostC in Dose-Dependent Fashion
IS measured in PostC-treated rats receiving one cycle (31.10 Ϯ 2.86%) or two cycles (28.36 Ϯ 4.53%) of PerC intervention with 5 min of limb ischemia followed by 5-min reperfusion was not lower compared with PostC alone (29.52 Ϯ 5.12%; P Ͼ 0.05 for both). Similarly, when four cycles of PerC treatment were delivered with 1-or 3-min limb ischemia followed by reperfusion, the PostCϩPerC maneuver did not produce extra protection compared with PostC alone (IS, 1 min: 29.18 Ϯ 2.78%; IS, 3 min: 28.74 Ϯ 2.60%; P Ͼ 0.05 for both). In contrast, IS measured in PostC-treated rats combined with three cycles (24.06 Ϯ 2.85%) or four cycles (22.00 Ϯ 3.87%) of PerC (each cycle being 5-min ischemia followed by 5-min reperfusion) was lower compared with PostC alone (P ϭ 0.023 and P ϭ 0.002, respectively), with no difference between the PerC regimes. (Fig. 4) . Fig. 3 . In protocol III, SD rats were randomly assigned into 4 groups: 1) IR group, in which SD rats underwent open-chest operation and after a 50-min stabilization period, I/R injury was induced as described in Fig. 2; 2) IPC group, in which after a 10-min stabilization period, IR group rats received IPC therapy as described in Fig. 2; 3) PostCϩPerC group, in which IR group rats were given both PostC and PerC treatments as described in Fig. 2; and 4 ) IPCϩ PostCϩPerC group, in which IR group rats received IPC, PostC, and PerC treatments. Some rats from each group were killed for IS measurement at the completion of 2-h reperfusion, while other rats were killed at 15 min of reperfusion for Western blotting to quantify activity of signaling pathways.
Cardioprotective Effects Between Different Modalities of Therapy
Compared with the IR group (48.89 Ϯ 6.66%), there was a decrease in IS in both PostC (29.39 Ϯ 3.66%) and PerC (33.49 Ϯ 5.81%) group rats (P Ͻ 0.01 for both), with no difference between the two groups. A greater degree of protection was observed with IPC intervention (18.8 Ϯ 2.54%) than PostC or PerC treatment alone (P Ͻ 0.01 for both), although a combination of PostC and PerC (4 ϫ 5-min cycles) therapy (22.56 Ϯ 4.45%) achieved the same beneficial effects as conferred by IPC alone (P Ͼ 0.05) (Fig. 5, A and B) . Risk area was similar among the five different groups (data not shown).
During both the ischemia and reperfusion periods, there were increases in heart rate and LVEDP and a significant decrease in MAP, ϩdP/dt max , and ϪdP/dt max in each group compared with the data at baseline. Data for individual groups are presented in detail in Table 1 , but during the reperfusion period essentially only the IPC and combined PostCϩPerC groups showed a statistically significant difference in LVEDP (lower) and ϩdP/dt max (higher) compared with the IR group (Table 1) .
At completion of reperfusion, consistent with the IS data, TUNEL staining showed a lower percentage of positive-staining cells in both PerC (28.45 Ϯ 4.67%) and PostC (25.32 Ϯ 4.56%) rats than in IR group rats (35.80 Ϯ 5.31%; P Ͻ 0.05 for both). However, the lowest percentage of apoptotic cells was seen in IPC (16.15 Ϯ 2.80%) and PostCϩPerC (21.08 Ϯ 4.12%; P Ͻ 0.05 for both; Fig. 5C ) groups. In line with TUNEL staining, enhanced ratio of Bcl-2/Bax protein expression was higher in both PerC and PostC rats compared with IR group rats (P Ͻ 0.05 for both), with a further increase in the IPC and combination groups (P Ͻ 0.05 for both; Fig. 5D ).
Total ERK1/2 and total Akt expression were not significantly different among the five groups (Fig. 5, E and F) . Survival kinase activation, specifically the phosphorylation levels of Akt and ERK1/2 at 15 min of reperfusion, was significantly induced by both PostC and PerC alone (P Ͻ 0.05 for both) compared with IR group rats. The greatest phosphorylation level was detected in IPC (P Ͻ 0.05, respectively), and combination therapy reached a level similar to that seen with IPC (P Ͼ 0.05; Fig. 5, E and F) .
There was a unique pattern of the time course of ROS generation for each modality of treatment. At 1 min of reperfusion, both IPC and PerC group rats produced a lower level of superoxide anion measured by lucigenin-enhanced chemiluminescence than IR group rats (P Ͻ 0.05 for both), with no difference between the two groups (P Ͼ 0.05). Notably, PostC therapy resulted in a greater decrease in superoxide anion generation at 1 min of reperfusion (P Ͻ 0.05); however, combination of PostC and PerC treatment did not produce additional protection against superoxide anion generation compared with PostC alone (P Ͼ 0.05) (Fig. 6A) . At 5 min of reperfusion, IR group rats showed an abrupt increase in superoxide anion generation that was twofold higher than at 1 min of reperfusion (P Ͻ 0.05). The four treatment groups also showed significant increases in superoxide anion generation at 5 min; however, PostC and PerC showed similar protection against superoxide anion generation, with levels lower than those in IR group rats (P Ͻ 0.05 for both). IPC achieved the lowest level (P Ͻ 0.05 for both) compared with PostC and PerC, although not statistically different from that achieved with combined PostCϩPerC (P Ͼ 0.05) (Fig. 6A) . This general pattern of differences persisted throughout the reperfusion period, albeit with progressively lower absolute levels at each time point (Fig. 6, A and B) .
Similar to lucigenin-enhanced fluorescence quantification, at 1 min of reperfusion IPC and PerC group rats showed lower MDA levels compared with IR group rats (P Ͻ 0.05 for both), while a further decrease in MDA generation was observed in both PostC and PostCϩPerC groups (P Ͻ 0.05 for both; Fig.  6C ). At 5 min of reperfusion, each group manifested a signif- icant increase in MDA level compared with 1 min of reperfusion. While both PerC and PostC groups demonstrated lower MDA levels than the IR group (P Ͻ 0.05 for both), the lowest level of MDA was observed in the IPC group, which was not different from the PostCϩPerC group (P Ͻ 0.05; Fig. 6C ). At both 10 and 30 min of reperfusion the MDA levels were not different from that at 5 min of reperfusion. However, there was a further increase in MDA generation at 60 min of reperfusion for each group, and MDA generation reached the peak value at the end of reperfusion. Again, the relative difference between groups at these time points of reperfusion remained in the same pattern as at 5 min of reperfusion (Fig. 6, C and D) .
The PI3K and ERK1/2 inhibitors had no effects on IS in IR group rats. However, the protective effects of PostC combined with four cycles of limb ischemia and reperfusion (22.25 Ϯ 3.88%) was completely abolished by either the PI3K (46.83 Ϯ 4.31%) or the ERK1/2 (49 Ϯ 3.73%) inhibitor (P Ͻ 0.001 for both) (Fig. 7, A and B) . Interestingly, the ERK1/2 inhibitor appeared to inhibit the activation of Akt phosphorylation level somewhat; however, this did not reach statistical significance. Akt inhibitor did not affect the activity of ERK1/2 (Fig. 7, C  and D) .
PostCϩPerC Therapy Does Not Add to Cardioprotection Afforded by IPC
When the PostCϩPerC maneuver was added to IPC, no further additive effects were observed (Fig. 8, A and B) . IS in the IPC group (18.68 Ϯ 2.1%) was similar to that in either the PostCϩPerC group (22.07 Ϯ 3.35%) or the IPCϩPostCϩPerC group (19.62 Ϯ 2.89%; P Ͼ 0.05 for both). Consistent with this finding, no further increase in Akt or ERK1/2 phosphorylation level was detected at 15 min of reperfusion in IPC combined with PostCϩPerC (Fig. 8, C and D) .
DISCUSSION
This is the first study to compare the myocardial protective effects of classical IPC with the more clinically relevant methods of remote PerC and PostC in combination. We showed that PerC produces an additive effect to PostC in a dose-dependent fashion, with maximal protection being present when PostC was preceded with PerC delivered with four cycles of 5-min limb ischemia followed by 5-min reperfusion. This combination therapy showed similar protection compared with IPC therapy alone. The additive effects of PostC and PerC were associated with enhanced Values are means Ϯ SD. IR, ischemia ϩ reperfusion; IPC, ischemic preconditioning; PostC, ischemic postconditioning; PerC, ischemic perconditioning; HR, heart rate; MAP, mean arterial pressure; LVEDP, left ventricular end-diastolic pressure; ϩdP/dtmax, maximal rate of increase in intraventricular pressure; ϪdP/dtmax, maximal rate of decrease in intraventricular pressure. *P Ͻ 0.05 vs. Baseline; †P Ͻ 0.05 vs. IR group. phosphorylation levels of Akt and ERK1/2 compared with PostC or PerC alone, and their protective effect was blocked by either a PI3K or a ERK inhibitor. Finally, when combined PostCϩPerC treatment was added to IPC, no further additive effects were observed in terms of IS or phosphorylation levels of Akt and ERK1/2.
Dose-Dependent Additive Protection Offered by PerC to PostC Treatment
While an early study suggested that the protection induced by IPC was an all-or-none phenomenon (32), Sandhu et al. (41) observed that IPC produced cardiac protection in a dosedependent fashion. Using a rabbit model of I/R induced by 30-min ischemia followed by 90-min reperfusion, they demonstrated that by increasing the number of the cycles of IPC there was stronger protection against I/R injury. This phenomenon was confirmed by Schulz et al. (44) in a pig I/R injury model. Moreover, the protection conferred by a higher dose of IPC therapy was more resistant to pharmacological blockers of specific signaling pathways (41) . However, it is difficult to derive an optimal protocol by which a maximal protection was achieved, as it depends on the species and severity of I/R injury (13) . In our present study we used an intensified protocol using four cycles of 5-min coronary ligation followed by 5-min reperfusion compared with only one cycle of IPC maneuver (5-min ischemia period) in a rat I/R model (29) . A significant reduction in IS, ϳ50% reduction compared with I/R control rats, was achieved in our study. Moreover, this protection cannot be further enhanced by adding PostCϩPerC intervention, suggesting that "maximal" protection was obtained by using this algorithm of IPC specifically in this study.
A dose-response phenomenon has also been observed in PostC therapy (46) . While related to the duration of index ischemia (34, 49) , the magnitude of the dose-response effect appears to be smaller, presumably because of the limited time window available (29, 52) . This may explain why the protective effects of PostC may not be fully comparable to IPC. In a rat I/R injury model, Kin et al. (29) demonstrated that when the therapeutic intervention was delayed beyond 1 min after the onset of reperfusion, protection was lost. In the present study, PostC delivered during the first 2 min of reperfusion was unable to replicate the degree of cardioprotection afforded by IPC.
PerC potentially provides an adjunctive method to maximize the protection effects of PostC, and both are applicable in the clinical setting. Indeed, in this study we purposely delivered the PerC therapy at the end of the index ischemia period to mimic the clinical situation because the therapy is usually delivered at the late phase of an ischemic episode (28) . When combined with PostC, there was a clear dose response. If the duration of limb ischemia was shortened to 1 or 3 min or the number of cycles of maneuver was reduced below three, then the combination of PostC and PerC did not produce additive protection. Conversely, when three or four cycles of 5-min ischemia and 5-min reperfusion were used, then the combination of PostCϩPerC recapitulated the effects of IPC. It is not clear whether more cycles of either PerC or PostC would lead to greater protection, either alone or in combination, but the time constraints of our ischemic duration, and the need for early treatment during reperfusion, made additional PerC and PostC unfeasible within this protocol, and probably irrelevant in terms of clinical relevance.
Activation of Reperfusion Injury Salvage Kinase
Although our understanding of the detailed mechanisms via which IPC or PostC confers cardioprotection remains incomplete, it has previously been shown that both IPC and PostC can activate the survival kinases at the early reperfusion period (18) , among which Akt and ERK1/2 are the two key components of the RISK pathway. Our data showed that combined PostC and PerC can further activate the RISK pathways compared with PostC or PerC alone, which in turn was clearly associated with improved cardioprotection as evidenced by reduction in IS, less apoptosis activity in the peri-infarct area, and increased antiapoptotic protein expression. The greatest decrease in IS, and recovery of cardiac performance, was shared by IPC and PostCϩPerC. However, while unlikely, we cannot fully exclude that this improved cardiac function was due to a recovery of stunned myocardium. Nevertheless, better cardiac hemodynamic data were observed only in IPC-and PostCϩPerC-treated rats. More importantly, the cardioprotection was abolished by either PI3K or ERK1/2 inhibitors, further supporting the role for these two signaling pathways in these forms of cardioprotection.
Our data further are supportive of a previous study demonstrating the limitation of PostC alone in IS reduction (29) . Furthermore, while the role for PI3K/Akt pathway has been shown in a rat animal model (50) , the activity of ERK was not tested in that study. There may be important interspecies differences, however. Indeed, Darling et al. (11) demonstrated that PostC limited IS via activation of ERK1/2 pathway rather than PI3K/Akt signaling pathway in a rabbit model. The role of PI3K/Akt and ERK1/2 was also questioned by another study in which these two pathways were activated without evidence of cardioprotection by PostC (45) in a pig model. Recently, Heusch and colleagues reported that the activation may not be necessary for cardioprotection by PostC (47), with survivor activating factor enhancement (SAFE) pathway playing an important role (21) . However, the alternative integrated signaling pathway involved still cannot explain previous negative data failing to show an effect of PostC in some models (15) or explain these conflicting data in the prior literature (46) . Nonetheless, our data indicate that PostC is a partially effective cardioprotective strategy that at least in part is mediated via activation by survival kinase activation, which when augmented by PerC provided cardioprotection equivalent to IPC. Furthermore, when a combination of PostCϩPerC was added to IPC, this did not show a further cardioprotection. The same phenomenon has been observed in previous studies (16, Fig. 7 . A: representative sequential LV slices from each group (see protocol IIB for details) showing both area at risk delineated with Evans blue staining for normal heart tissue and area of necrosis with TTC staining (pale area ϭ infarcted tissue). B: % of LV weight of infarct area over LV weight at area at risk. C and D, top: representative Western blotting for phospho-Akt and total Akt (C) and phospho-ERK1/2 and total ERK1/2 (D). C and D, bottom: expression ratio of phospho-Akt over total Akt and phospho-ERK1/2 over total ERK1/2, respectively. All protein expressions are adjusted by ␤-actin level for protein loading. All data are expressed as means Ϯ SD. *P Ͻ 0.01 vs. IR group; &P Ͻ 0.05 vs. PostCϩPerC group. Other abbreviations are defined as in Fig. 1. 50), However, in a rabbit I/R injury model, additive effects were observed when the index ischemia period increased from 30 min to 45 min (52).
Pattern of Attenuated Superoxide Anion Generation in Reperfusion
Redox signaling acts as second messenger in triggering the cardiac protection pathways for both IPC (3, 8) and PostC (12, 37) . With classical IPC, ROS generation at reperfusion activates PKC, which in turn greatly increases the sensitivity to adenosine agonists, such as endogenous adenosine that is released from ischemic cardiomyocytes (31) . The importance of redox signaling at early reperfusion has also been demonstrated in PostC (38) . Cohen et al. (10) demonstrated that the acidic pH maintained by modified reperfusion with intermittent reperfusion can also generate ROS to activate PKC and prevent mitochondrial permeability transition pore (mPTP) opening. Consequently, redox signaling at early reperfusion leads to the activation of a common RISK pathway (18) and hence prevents mPTP opening in both IPC (17) and PostC (2), although this protective effect of a "burst" of ROS production to initiate cardioprotection must be contrasted to the effects of sustained ROS accumulation during reperfusion, which clearly contributes to the cell death (4, 6) . In previous studies both IPC (40, 51) and PostC (48, 53) were associated with a greater attenuation of ROS generation early after the onset of reperfusion. Our study, for the first time, directly compared the effects of IPC, PostC, and PerC on myocardial ROS production and MDA accumulation. While PostC resulted in the lowest ROS generation at 1 min of reperfusion, for the remainder of the reperfusion period IPC exhibited more powerful effects than PerC or PostC alone in terms of preventing ROS generation or MDA accumulation. More importantly, the pattern of attenuated ROS generation with the different conditioning strategies was clearly consistent with survival kinase activation detected at 15 min of reperfusion. This supports the notion that survival kinase activation initiated during the early phase of reperfusion plays an important role in protecting against reperfusion injury (18) . In our study, the strongest kinase activation was seen with local IPC and combined PostCϩPerC, and that was associated with lowest ROS generation and IS compared with PerC or PostC alone. Overall, therefore, our data demonstrated that a combination of PostC and PerC essentially recapitulated the effects of IPC. This is important because classical IPC, which necessitates a transient ischemic insult to be applied to the myocardium before a predictable insult, has limited clinical utility. By contrast, both PerC and PostC can be used as salvage interventions after the onset of established ischemia. While it appears that neither PostC nor PerC is as effective as IPC when used alone in our rat model, when applied in combination they are equipotent to IPC in terms of IS limitation and reduction in apoptosis. Thus it may well be that optimal myocardial salvage in human I/R syndromes will similarly be obtained by using a combined strategy. 
Limitations of Study
There are several limitations in the present study. First, time course changes in superoxide anion generation were measured for each group of rats. While cardioprotection was associated with different degrees of survival kinase activation and ROS generation, the exact mechanisms of MDA accumulation and attenuation of superoxide anion level during reperfusion remain to be fully described. The beneficial component of ROS that initiates the RISK activation cannot be differentiated from detrimental ROS generation (37) . Second, we observed variable ROS generation with different modalities of ischemic conditioning therapy. It has been shown that attenuation of ROS generation can result in reduced myocardial stunning, which is also closely related to the metabolic status of the myocardium (22) . However, we did not attempt to measure the mitochondrial respiratory function as a reflection of possible stunning. Thus we cannot determine whether the improved cardiac performance observed in both IPC and combination group rats was due to the lower IS or an earlier recovery of stunned myocardium. Third, although the role for Akt and ERK1/2 activation in the process of cardiac protection was demonstrated, it does not exclude a potential role for alternative pathways involved in the process. In addition, while the activation of RISK pathway was associated with reduced apoptosis, there was overall a fairly high percentage of apoptotic cells in the present study. We think this is likely related to the sensitivity of the specific kit we used. Indeed, a similar percentage value was also reported in another study (25) using the same technique. Nevertheless, statistical differences were clearly demonstrated between groups, which were further confirmed with Bcl-2/Bax protein expression ratio. Finally, our data showed no additive effect when PostCϩPerC therapy was added to IPC, but these findings can only be interpreted in the light of the ischemia duration chosen for our studies and the rat model used. It is possible that there will be species differences, and that combination therapy might have a greater role with different ischemia durations.
In summary, we have shown that with commonly applied conditioning protocols, IPC is superior to PerC and PostC alone. However, when used in combination, PostCϩPerC largely recapitulates the cardioprotection afforded by IPC. These findings may have relevance to clinical cardioprotection strategies, particularly in optimizing myocardial salvage during emergency percutaneous coronary intervention (PCI) for evolving myocardial infarction.
